Form 4: Liquidia Corp's Chief Medical Officer Rajeev Saggar Reports Stock Sale to Cover Taxes

Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes associated with the vesting of restricted stock units.

Summary

• On January 21, 2025, Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, sold 2,445 shares of common stock at a price of $13 per share.
• The sale was executed to cover taxes associated with the settlement of restricted stock units (RSUs) that vested on January 18, 2025.
• Following the transaction, Saggar directly owns 267,943 shares of Liquidia Corp.
• This includes unvested RSUs granted on July 18, 2022, January 11, 2023, January 11, 2024 and January 11, 2025, as well as shares acquired under the Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock transactions by a company insider; it doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock; this provides transparency to the market.

Stakeholder Impact

• The stock sale by a company insider could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial condition.

Key Dates